Successful execution of the said project will surely help the company but investment decisions should not be dependent on a particular company update.
Posts in category Value Pickr
Stock SIP boring yet powerful (14-08-2024)
If we see the trend in this back test, it is averaging down from Jan 2018 to March 2020 (more than 2 years of bear mkt for this stock). One needs high conviction and patience for this strategy to work. It’s easy to invest based on hindsight information, real time may not be that easy. Just my 2 cents.
Stock SIP boring yet powerful (14-08-2024)
If we see the trend in this back test, it is averaging down from Jan 2018 to March 2020 (more than 2 years of bear mkt for this stock). One needs high conviction and patience for this strategy to work. It’s easy to invest based on hindsight information, real time may not be that easy. Just my 2 cents.
Mukka Proteins-Newly listed company worth studying (14-08-2024)
Mukka Proteins has announced a strategic investment in its associate company, Ento Proteins Private Limited. The company has subscribed to a rights issue, acquiring an additional 1,847 equity shares at a premium of Rs. 37,817 per share, for a total investment of Rs. 7 crore. This transaction increases Mukka Proteins’ stake in Ento Proteins to 74%.
Ento Proteins is a manufacturer of insect meal and insect oil, a segment gaining traction due to its potential as a sustainable protein source.
Mukka Proteins-Newly listed company worth studying (14-08-2024)
Mukka Proteins has announced a strategic investment in its associate company, Ento Proteins Private Limited. The company has subscribed to a rights issue, acquiring an additional 1,847 equity shares at a premium of Rs. 37,817 per share, for a total investment of Rs. 7 crore. This transaction increases Mukka Proteins’ stake in Ento Proteins to 74%.
Ento Proteins is a manufacturer of insect meal and insect oil, a segment gaining traction due to its potential as a sustainable protein source.
Prevest Denpro Limited (14-08-2024)
I think the reason for no growth in revenues and decline in margins is same…dwindling exports. They used to make more margins in exports. Domestic sales have lower margins.
I was very interested in the company. But was uncomfortable with the high salary drawn by the promoter family, and then S-I-L was also onboarded at a high salary. Thank God I didnt invest.
Prevest Denpro Limited (14-08-2024)
I think the reason for no growth in revenues and decline in margins is same…dwindling exports. They used to make more margins in exports. Domestic sales have lower margins.
I was very interested in the company. But was uncomfortable with the high salary drawn by the promoter family, and then S-I-L was also onboarded at a high salary. Thank God I didnt invest.
Anuh pharma ltd (14-08-2024)
Hi, any insights on how they will achieve 16% CAGR since no new CAPEX is there in balance sheet, also Q1 results are miss when sector overall is doing good